Johnson & Johnson today announced the launch of Every Mother, Every Child, a comprehensive, five-year, private-sector effort to improve the health of women and children in developing countries. The initiative supports the United Nations’ April 2010 call for a renewed effort to achieve the Millennium Development Goals (MDGs) of reducing mortality in women and children by 2015.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/calraisins/46028/
Legacy®, through an unrestricted educational grant from Genentech, launches two new resources devoted to helping smokers understand their risks for lung cancer and reducing their risks for mortality.
Lung cancer is the nation's number one cancer killer of both men and women, accounting for 28 percent of all cancer deaths. More Americans are killed by lung cancer than by breast cancer, prostate cancer, or any other cancer. Up to 90 percent of lung cancer cases result from smoking and no current treatment can cure lung cancer. Early detection is the key to better quality and longevity of life.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/legacy/47244/
A study published in the Journal of Infectious Diseases indicates that treatment with oseltamivir significantly reduces mortality in patients with influenza A/H5N1, or ‘bird flu,’ even when given late in the course of illness.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/outcome/46648/
Save the Children and The Advertising Council announced today the launch of a national multimedia public service advertising (PSA) campaign designed to raise awareness of the preventable and treatable causes of childhood death in the developing world. The new campaign shows Americans that they can have a significant impact on saving and improving the lives of at-risk children and newborns by supporting the deployment of local health workers.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/adcouncil/43767/
The largest-ever morbi-mortality study of treatments for chronic heart failure has shown that adding the specific heart rate lowering agent Procoralan® (ivabradine) to standard therapy significantly reduces the risk of death and hospitalisation for heart failure.1 Results from this new study, SHIFT (Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial), were presented today at the European Society of Cardiology1 in Stockholm and published in The Lancet.2
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shift/44195/
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, reported that The New England Journal of Medicine today published results from Cohort B of The PARTNER Trial, which studied the Edwards SAPIEN transcatheter heart valve for the treatment of severe aortic stenosis. The results of the trial successfully met the primary endpoints of all-cause mortality and mortality plus repeat hospitalization.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/edwardslifesciences/44227/
Today Safe Kids Worldwide released a new research report that found while the death rate among children from poisoning has been cut in half since the late 1970s, the percentage of all child poisoning deaths due to medications has nearly doubled, from 36 percent to 64 percent.
Safe Storage, Safe Dosing, Safe Kids: A Report to the Nation on Safe Medication examines trends in morbidity and mortality of medication poisoning among children ages 14 and under. The report underscores the challenge of medication-related poisoning among children and offers solutions that will reverse the trends. Safe Kids also proposes specific roles that parents and other caregivers, industry, governments, and the medical community can play in improving medication safety through safe storage and safe dosing.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55155-safe-kids-worldwide-medication-safety-campaign-research-report
Johnson & Johnson today announced the launch of Every Mother, Every Child, a comprehensive, five-year, private-sector effort to improve the health of women and children in developing countries. The initiative supports the United Nations’ April 2010 call for a renewed effort to achieve the Millennium Development Goals (MDGs) of reducing mortality in women and children by 2015.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/jnj/46066/
Surmang Foundation has operated a primary care clinic in a remote, poor region of Western China, in partnership with the Chinese Government, Qinghai Province, and Yushu Prefecture, since 1992. The Core Project has treated over 60,000 patients for free, including medicine, since the clinic building was completed in 1996. Its focus is on the maternal and child mortality/morbidity rates of the region, among the highest in the world. It supports two local ethnic Tibetan doctors, Phuntsok Dongdrup and Sonam Drogha.
In our catchment area, the average annual income is about $50. Surmang Foundation’s remote site is a test case and a model for all of rural China, because impoverished nomadic Tibetans manifest in the extreme, most rural health and poverty problems. In cooperation with the Chinese Government and several hospitals, Surmang Foundation is currently expanding its mission to address the lack of access to basic services among the 28 million impoverished residents of rural, Western China and the lack of capacity of the local medical providers.
The pilot project will create a network of remote providers for IT-based distance medical education and remote diagnosis and referral. The pilot began in 2005 with the promulgation of an archive of all Tibetan and Chinese language health promotion materials and continued in 2006 with the installation of a satellite dish at the Surmang campus.
A part of that is the Community Health Worker Project funded by an AmCham grant in Spring 2005.
Surmang Foundation has partnered with the Soong Ching-ling Foundation since November 2005.
Nearly five black women die needlessly per day from breast cancer in the United States – a total of 1,722 deaths annually – according to a study released today at the Avon Foundation Breast Cancer Forum and simultaneously published in Cancer Epidemiology. The 2012 Racial Disparity in Breast Cancer Mortality Study found that 21 of the 25* largest U.S. cities have a black: white disparity in breast cancer mortality, 13 of which are statistically significant.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52895-avon-foundation-breast-cancer-forum-racial-disparity-mortality-study
A baby’s birth day is the most dangerous day of life — in the United States and almost every country in the world — according to Save the Children’s State of the World’s Mothers report, released today.
Yearly, more than 1 million babies die the day they are born, according to the first global analysis of newborn day-of-death data.
In addition to newborn findings, the report features Save the Children’s Mothers’ Index, released annually before Mother’s Day. It ranks Finland as the best place in the world to be a mother, and Democratic Republic of the Congo as the toughest. The United States ranks 30th best.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61598-save-the-children-mothers-index
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Merck for Mothers has launched programs aimed at decreasing the number of women across the United States who die from or suffer severe complications related to pregnancy and childbirth.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/62776-merck-for-mothers-working-to-reduce-maternal-mortality-rate
